In a world first and taking diabetes management to a new level, the Paradigm™ Veo™ insulin pump with Continuous Glucose Monitoring is equipped with a Low Glucose Suspend (LGS) mechanism, which will halt insulin delivery automatically whenever your glucose levels reach a pre-set low.* This may help to reduce the risk of severe hypoglycaemia.1,2,3,4 And being a REAL-Time insulin pump, the Paradigm™ Veo™ system can offer you the advanced insight of Continuous Glucose Monitoring as well. Giving you and your Healthcare Professional information needed to make therapy adjustments:
- Monitoring and recording your glucose levels 24/7
- Allowing you to identify trends and make appropriate adjustments to your lifestyle/treatment**
- Warning you when your glucose levels stray from your target range
While research shows that CGM helps manage diabetes better5, we understand that not everybody is ready to monitor their glucose levels in this way. You may, for example, choose to continue with your existing fingerstick routine only. That’s why we refer to the Paradigm™ Veo™ insulin pump as “CGM-Ready”, which means you can switch CGM functionality on or off at any time – depending on your preferences and requirements. With the CGM function off, you will keep on enjoying the benefits of the Paradigm™ Veo™ as an insulin pump in its own right.
- Smart - Medtronic Bolus Wizard™ Calculator - does the calculations for you and suggests bolus amounts
- Individual - 5 colour options and a range of SKINS allow you to personalise your pump
- Freedom - You have the freedom to set your own routine so you can eat, sleep and exercise whenever you like.
- Easy to use - Simple, intuitive navigation and on-screen instructions
- Helpful - Missed meal bolus reminder – may help avoid hyperglycaemia by warning you when a meal bolus may have been missed.
- Discreet - No bigger than a mobile phone, and will attach to a belt or fit in a pocket
We understand how difficult choosing an insulin pump can be. That’s why key features and benefits are listed in a table below. The Paradigm™ Veo™ Insulin pump has a number of innovative features that may help you to manage your diabetes more easily.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
To download further information (user guides, fact sheets,
etc), please click
here.
To access the ParadigmTM VeoTM tutorial, click
here
1 Attia N, et al. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and int eh treatment of acutely decompensated IDDM. Diab Care. 1998;21(5):817-821.
2 Buckingham B, et al. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diab Tech Thera. 2009;11(2):93-97.
3 Guerci B, et al. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endo Metab. 1999;84(8):2673-2678.
4 Zisser H. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diab Care. 2008;31:238–239.
5. Deiss D, et al. Improved glycemic control in poorly controlled patients with type 1
diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-32.
*Requires the addition of an optional Medtronic MiniLink™ transmitter and glucose sensor to your insulin pump.
** Confirmatory fingerstick is required prior to making any therapy adjustment.


























